<DOC>
	<DOCNO>NCT02402933</DOCNO>
	<brief_summary>Up fifty ( 50 ) child adolescent type 1 diabetes ( T1D ) age 4 Ë‚18 year time enrolment select inclusion study . The target obtain treatment response user-experience data follow use AMG504-1 treat episode hypoglycemia .</brief_summary>
	<brief_title>Clinical Usability Intranasal Glucagon Treatment Hypoglycemia Children Adolescents</brief_title>
	<detailed_description>This study propose evaluate effectiveness intranasal ( IN ) glucagon administer clinical use condition treat episode hypoglycemia person T1D . This study also aim assess ease caregiver administer experimental medication treatment hypoglycemic event .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Availability entire study period . Motivated Child/Adolescent diabetes ( C/AWD ) caregiver ( ) absence intellectual problem likely limit validity consent participate study compliance protocol requirement ; ability cooperate adequately ; ability understand observe instruction qualify investigator designee . C/AWD live one caregiver available administer glucagon case episode severe moderate hypoglycemia . Male female C/AWD history type 1 diabetes &gt; 1 year . C/AWD age least 4 year age less 18 year . A female C/AWD must meet one follow criterion : ) Participant childbearing potential agrees use one accept contraceptive regimen throughout entire duration study ( pretrial evaluation enrollment visit study completion ) . An acceptable method contraception include one following : ( ) Abstinence heterosexual intercourse ( ii ) Systemic contraceptive ( birth control pill , injectable/implantable/ insertable hormonal birth control product , transdermal patch ) ( iii ) Intrauterine device ( iv ) Condom spermicide , OR b ) Participant nonchildbearing potential , defined female hysterectomy tubal ligation , clinically consider infertile yet reach menarche . In good general health condition could influence outcome trial , judgment Investigator suitable candidate study base review available medical history , physical examination clinical laboratory evaluation . Willingness adhere protocol requirement . Females pregnant accord positive urine pregnancy test , actively attempt get pregnant , lactate . History significant hypersensitivity glucagon , relate product well severe hypersensitivity reaction ( angioedema ) drug . Presence cardiovascular , gastrointestinal , liver kidney disease , condition judgment investigator could interfere absorption , distribution , metabolism excretion drug could potentiate predispose undesired effect . Presence history pheochromocytoma ( i.e . adrenal gland tumor ) insulinoma . Use daily systemic betablockers , indomethacin , warfarin anticholinergic drug . Concomitant maintenance therapy drug would influence outcome trial , discretion Investigator Sponsor . Regular consumption 3 unit alcoholic beverage per day . Current participation another clinical trial , intent enroll another clinical trial clinical study use Investigational Product ( another clinical trial ) within prior 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>